Your browser doesn't support javascript.
Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease.
Wellens, Judith; Brann, Stephanie; Adams, Alex; Marlow, Luke; Lindsay, James O; Satsangi, Jack J.
  • Wellens J; Translational Gastro-intestinal Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK; Translational Research for Gastrointestinal Diseases, University Hospitals Leuven, Leuven, Belgium. Electronic address: judith.wellens@kuleuven.be.
  • Brann S; Translational Gastro-intestinal Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK.
  • Adams A; Translational Gastro-intestinal Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK.
  • Marlow L; Translational Gastro-intestinal Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK.
  • Lindsay JO; Barts Health NHS Trust, The Royal London Hospital, London, UK; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine Queen Mary University of London, London, UK.
  • Satsangi JJ; Translational Gastro-intestinal Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Lancet Gastroenterol Hepatol ; 7(6): 507, 2022 06.
Article in English | MEDLINE | ID: covidwho-1773862
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2022 Document Type: Article